Li, Roger http://orcid.org/0000-0003-1274-7200
Article History
First Online: 4 October 2023
Competing interests
: R.L. declares research support from Predicine, Veracyte, CG Oncology, Valar Labs and Merck. R.L. declares positions on the clinical trial protocol committee for CG Oncology, and scientific advisor and/or consultant positions at Bristol Meyers Squibb, Merck, Fergene, Arquer Diagnostics, Urogen Pharma, Lucence, CG Oncology and Janssen.